Luis E. Raez
Luis E. Raez/X

Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors

Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on X/Twitter:

“Our metanalysis in Frontiers confirming there is no really benefit adding anti-VEGF to TKIs for EGFR tumors. Congrats to the Peruvian team from Aliada for putting this together!”

Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors

Read further.

Source: Luis E. Raez/X